Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05371054
Title Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

anaplastic large cell lymphoma

B-cell lymphoma

peripheral T-cell lymphoma

adult T-cell leukemia/lymphoma

angioimmunoblastic T-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Prednisone + Venetoclax + VIP152

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.